The Dubai Health Authority (DHA) has launched a new unified electronic platform to monitor the dispensing of opioid pain medication to all government and private health facilities in partnership with the Ministry of Interior.

By adopting this platform, DHA has succeeded in eliminating paper transactions related to dispensing these medications, said a statement from the Authority.
The platform also helps prevent these drugs from being misused in a non-medical and legal manner, which may be a danger to the lives of individuals and the community, it added.
 
Dr Marwan Al Mulla, Director of the Health Regulation Sector at the DHA said the platform was launched by the Authority as per international standards to monitor these medications in all stages until it reaches consumers through legitimate channels in line with the laws and regulations of the country.
 
He stressed the need for medical facilities to abide by the new rules, and to adhere to the provision of medicines through the e-platform.
 
The e-platform, he stated, was launched as part of the DHA's keenness to strengthen drug control and develop it continuously, in order to ensure the safety of Dubai's community and the health of its members.
 
It is also in line with the smart transformations adopted by the authority, to meet the directives of the Government of Dubai of going completely paper free by 2021 as the e-platform depends on smart paper-free technologies.-TradeArabia News Service

Copyright 2019 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.